Please login to the form below

Not currently logged in
Email:
Password:

Helen Parfitt joins Research Partnership

She takes on role as head of its Therapy Watch market tracking tool

Helen ParfittResearch Partnership has appointed Helen Parfitt as its new director, head of Therapy Watch - a ‘real-time’ syndicated global market tracking tool - in a role that will see her based at the firm’s head office in London.

Prior to joining the company, Parfitt has previously worked for IMS Health (now QuintilesIMS) as its director of core data assets, global technology services and operations, and subsequently as commercial director for M3 Group’s European division.

Her new role will see her join research directors Julia Godfrey and Laurent Chanroux in supporting the continued expansion of Therapy Watch, which currently runs global monitors in auto-immune, virology, oncology and nephrology.

She will also focus on the firm’s recently expanded oncology portfolio, which has added squamous cell carcinoma of the head and neck (SCCHN) and chronic myeloid leukaemia (CML) to its coverage.

Mark Jeffery, founding director of Research Partnership, said: “Helen brings with her a wealth of knowledge and expertise, her experience at GSK and Schering-Plough means she has also developed a strong understanding of clients’ needs.

“I believe she will be a strong asset to the Therapy Watch team and we look forward to her contributing to its continued growth and development.”

8th May 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics